Jagsonpal Pharmaceuticals standalone net profit declines 28.74% in the June 2024 quarter

Net profit of Jagsonpal Pharmaceuticals declined 28.74% to Rs 5.33 crore in the quarter ended June 2024 as against Rs 7.48 crore during the previous quarter ended June 2023. Sales rose 2.14% to Rs 61.44 crore in the quarter ended June 2024 as against Rs 60.15 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	61.44	60.15	2
OPM %	16.68	14.35	-
PBDT	11.47	10.48	9
PBT	10.40	10.09	3
NP	5.33	7.48	-29